🔗 Permalink

Inventor profile of:

Martyn Botfield

City:

Concord, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2023-07-06

Top Assignees for applications by Martyn Botfield

The entities that hold a legal rights for patent applications filed by inventor Botfield Martyn:

VERTEX PHARMACEUTICALS INCORPORATED 18 Cambridge, MA United States
VERTEX PHARMACEUTICALS INCORPORATED 9 Boston, MA United States
Vertex Pharmaceutical Incorporated 3 Cambridge, MA United States

Recent patent applications by Botfield Martyn

Martyn Botfield from Concord, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-07-06

US20230210839A1

Human necessities

PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF

#2 | 2021-01-28

US20210023070A1

Human necessities

Pharmaceutical composition and administrations thereof

#3 | 2017-03-30

US20170087144A1

Human necessities

Pharmaceutical composition and administrations thereof

#4 | 2014-11-20

US20140343098A1

Human necessities

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#5 | 2014-10-23

US20140315948A1

Human necessities

Pharmaceutical Composition and Administrations Thereof

#6 | 2014-10-09

US20140303204A1

Human necessities

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#7 | 2014-08-21

US20140235625A1

Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator

#8 | 2014-08-14

US20140228399A2

Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator

#9 | 2014-04-24

US20140113933A9

Chemistry; metallurgy

Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

#10 | 2014-04-24

US20140112988A1

Human necessities

Pharmaceutical Composition and Administrations Thereof

#11 | 2014-03-27

US20140088141A1

Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator

#12 | 2013-11-14

US20130303570A1

Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator

#13 | 2013-09-05

US20130231368A1

Chemistry; metallurgy

Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

#14 | 2013-08-01

US20130196983A1

Human necessities

Modulators of cystic fibrosis transmembrane conductance regulator

#15 | 2013-06-27

US20130165442A1

Chemistry; metallurgy

Modulators of ATP-binding cassette transporters

#16 | 2013-02-14

US20130040986A1

Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator

#17 | 2012-10-11

US20120258983A1

Human necessities

Pharmaceutical Composition and Administrations Thereof

#18 | 2012-08-30

US20120220625A1

Human necessities

PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF

#19 | 2012-08-16

US20120208841A1

Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator

#20 | 2011-10-20

US20110257223A1

Human necessities

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator

#21 | 2010-10-07

US20100256184A1

Human necessities

PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF

#22 | 2010-07-22

US20100184739A1

Chemistry; metallurgy

Modulators of ATP-binding cassette transporters

#23 | 2010-07-01

US20100168094A1

Human necessities

Modulators of cystic fibrosis transmembrane conductance regulator

#24 | 2010-05-27

US20100130547A1

Chemistry; metallurgy

Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

#25 | 2010-05-06

US20100113509A1

Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator

#26 | 2010-05-06

US20100113508A1

Chemistry; metallurgy

Modulators of cystic fibrosis transmembrane conductance regulator

#27 | 2010-03-25

US20100074949A1

Human necessities

Pharmaceutical composition and administration thereof

InventorID:

91844 ⎘